You just read:

Caris Life Sciences Biomarker Research Suggests Role for Immune-targeted Therapies in Subsets of Patients with Triple Negative Breast Cancer (TNBC)

News provided by

Caris Life Sciences

03 Jun, 2014, 12:00 BST